You can help save more lives

Today, 43 women in Australia will hear the life-changing words “You have breast cancer.”* 

Each of these women will face the heartbreaking task of telling their friends, their families and for some, their children. 

Sadly breast cancer is still the most common cancer in women in Australia. It is only through continued investment in research that we will be able to find a way to change the statistics for the women we love. 

With your support, the team of scientific and clinical researchers at Mater Research—our world-class research institute—are determined to find improved ways to diagnose, treat and ultimately prevent breast cancer. 

There are promising breast cancer projects happening right now at Mater—all thanks to your generosity. 

Trying to change the course of breast cancer treatment around the world 

Thanks to your support, Dr Snell recently completed a study that predicts which breast cancer patients are more likely to relapse on Tamoxifen, a drug commonly used to treat breast cancer.

His work shows that investigating the lymph node metastasis of breast cancer provides a better understanding of the disease, and enables clinicians to better predict which patients will relapse—therefore ensuring patients don’t have to waste precious time taking a drug that might not work.

Dr Snell’s work has shown that patients with negative Progesterone receptor (PR-) in the lymph node disease have a higher chance of relapsing on Tamoxifen treatment. This finding has the potential for immediate impact—translating Dr Snell’s work from the research lab to the patient’s bedside and allowing clinicians to test if Tamoxifen is the right drug for each breast cancer patient.


His research is extremely promising and has the potential to change the course of breast cancer treatment for women not just at Mater, but around the world. 

You can further help the women in your life affected by breast cancer. 

Please consider making a donation to Mater Chicks in Pink today and help fund this promising cancer research. 

Without your support, the breakthroughs that Mater researchers and clinicians are making would not be possible. The generous support of our donors is enabling Mater to make huge advances in cancer research—right in our own backyard.

Professor John Prins, Director and Chief Executive Officer—Mater Research.

*Source: Cancer Australia, 2016.